![Tillman E. Pearce](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Tillman E.
Pearce worked as a Senior Director of Clinical Research at Protein Design Labs, Inc. He was a Medical Director at Sanofi-Synthélabo SA from 1997 to 2002.
He also worked as a Director of Clinical Research at Novartis Pharma AG and as a Chief Medical Officer at Threshold Pharmaceuticals, Inc. Pearce was also the Chief Medical Officer at Humanigen, Inc. from 2007 to 2011.
Pearce holds a doctorate from Georgia Health Sciences University and an undergraduate degree from Tulane University (Louisiana).
Anciens postes connus de Tillman E. Pearce
| Sociétés | Poste | Fin |
|---|---|---|
| HUMANIGEN, INC. | Directeur Technique/Scientifique/R&D | 01/01/2011 |
Sanofi-Synthélabo SA
 Sanofi-Synthélabo SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cardiovascular treatment, central nervous system, internal medicine drugs and oncology treatment | Directeur Technique/Scientifique/R&D | 01/01/2002 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Directeur Technique/Scientifique/R&D | - |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur Technique/Scientifique/R&D | - |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Directeur Technique/Scientifique/R&D | - |
Formation de Tillman E. Pearce
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
Sanofi-Synthélabo SA
Sanofi-Synthélabo SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cardiovascular treatment, central nervous system, internal medicine drugs and oncology treatment | Health Technology |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Georgia Health Sciences University
 Georgia Health Sciences University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
